Abiopharma

🔍 Boctor Fady (Executive)

Company: Petros Pharmaceuticals, Inc. (PTPI)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 500,000 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 519,986.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

Footnotes:

• F1: Represents Restricted Stock Units ("RSUs"). 50% of the RSUs vested on the date of grant and the remaining 50% will vest on the six month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date. Each RSU represents the right to receive one share of common stock, par value $0.0001 per share (the "Common Stock"), of the Issuer.
• F2: Amounts adjusted for the Issuer's 1-for-25 reverse stock split of the Issuer's Common Stock, effective as of 4:05 p.m. (New York time) on April 30, 2025.
• REMARKS: President & Chief Commercial Officer